Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors
This study has been terminated.
University of California, San Francisco
Tobira Therapeutics, Inc.
Information provided by (Responsible Party):
Priscilla Hsue, University of California, San Francisco
First received: November 15, 2011
Last updated: May 16, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Estimated Study Completion Date:||June 2013|
|Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|